The more news generated about stem cells the better for SVFC
The more news generated about stem cells the better for SVFC. This is from a competitor site but indicates the positive progress going on in the field as well as the possibility of acquisition.
"The Global Revolution in Biotechnology and the Impact of Regenerative Medicine"
"This is the golden age of science." That's what Mike Milken, chairman of the Milken Institute, told CNBC's Kelly Evans on Monday during an interview with Milken and National Institute of Health director Francis Collins at the 5th Annual Partnering for Cures convention at the Grand Hyatt in Manhattan. Francis Collins referenced healthcare as being in an evolutionary period and noted that steps need to be taken for the United States to maintain a world leadership position. "When you look at the rest of the world, they have read America's playbook and have seen how success happened and they are trying to become what we used to be," commented Collins.
In our view, a cornerstone in a robust U.S. (and global) biotechnology ecosystem is regenerative medicine and many of the next generation treatments that cell-based therapeutics has to offer. The rapidly growing field as an adjunctive or front line treatment embodies a new wave of therapies to meet countless areas of great unmet medical need where legacy, small molecule-based drugs are showing limited impact, or facing extreme challenges. This impact is being recognized globally - a good example is Japan, which has embraced the potential of regenerative medicine and is actively seeking to establish itself as a global leader in the area. It has earmarked regenerative medicine specifically, announcing $3.2 billion in funding for programs to advance the area, using pluripotent stem cells and other approaches.